DRIZALMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 28 Jan 2026)
What this means for you
Registered since 31 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88363037
- Registration number
- 6025463
- Mark type
- Stylized text
- Filed
- 29 Mar 2019
- Published for opposition
- 16 Jul 2019
- Registered
- 31 Mar 2020
- Attorney of record
- Craig Kuchii, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurologic disorders, disorders of the nervous system, mental illness, major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain
Owner
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
Prosecution history
- 28 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 28 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 28 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 31 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Feb 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Feb 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Feb 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Feb 2020 — NON-FINAL ACTION E-MAILED
- 07 Feb 2020 — SU - NON-FINAL ACTION - WRITTEN